Imaging of neuroendocrine gastroenteropancreatic tumours
- PMID: 20221711
- DOI: 10.1007/s11547-010-0540-1
Imaging of neuroendocrine gastroenteropancreatic tumours
Abstract
The role of imaging in functioning endocrine tumours (FETs) is primarily to detect the tumour, that is, to verify lesion number and location. Radiological detection of carcinoid tumours is limited by typical tumour location throughout the gastrointestinal tract or appendix and is therefore dependent on the tumour being large enough to make it recognisable in that site. The most common FET is insulinoma, which is commonly characterised by the typical appearance of a hypervascular lesion at multidetector-row computed tomography and magnetic resonance imaging. A particularly important role is played by intraoperative ultrasound in defining the exact number of lesions, their relationship with adjacent vascular structures and the pancreatic duct for the purposes of correct surgical planning (enucleation or resection). In the setting of nonfunctioning endocrine tumours (NFETs), which manifest late as large masses causing compression symptoms or as incidental findings, imaging is not primarily aimed at tumour detection, as this is relatively easy given the large size of the lesions. Rather, its role is to characterise the tumour and, in particular, to differentiate pancreatic NFET from ductal adenocarcinoma, as in comparison, malignant NFETs have a more favourable prognosis (5-year survival rate 40% compared with 3%-5% for adenocarcinoma) and therefore require different treatment approaches. As NFET are often malignant, they also require accurate staging and appropriate follow-up. In 80% of cases, NFETs have a "typical" imaging appearance: location in the pancreatic head, large dimensions (diameter between 5 and 15 cm, >10 cm in 30% of cases), capsule, sharp and regular margins owing to the expansile and noninfiltrative growth pattern, solid density and arterial hypervascularity. Some 20% of NFETs display different imaging characteristics ("atypical" appearance) as a result of arterial hypovascularity due to the presence of abundant fibrous stroma. Lastly, a small percentage of NFETs has yet a different appearance ("unusual") due to the cystic nature and/or diffuse location throughout the pancreatic parenchyma.
Similar articles
-
Imaging of secretory tumors of the gastrointestinal tract.Abdom Radiol (NY). 2017 Apr;42(4):1113-1131. doi: 10.1007/s00261-016-0976-4. Abdom Radiol (NY). 2017. PMID: 27878636 Review.
-
Localisation of neuroendocrine tumours of the upper gastrointestinal tract.Gut. 1994 Apr;35(4):471-5. doi: 10.1136/gut.35.4.471. Gut. 1994. PMID: 8174983 Free PMC article.
-
Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):803-18. doi: 10.1016/j.bpg.2012.12.004. Best Pract Res Clin Gastroenterol. 2012. PMID: 23582920 Review.
-
[Radiodiagnostic techniques in gastroenteropathic neuroendocrine tumors].Endocrinol Nutr. 2009 Sep;56 Suppl 3:2-7. doi: 10.1016/S1575-0922(09)73503-X. Endocrinol Nutr. 2009. PMID: 20542213 Spanish.
-
Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors.Minerva Endocrinol. 2016 Dec;41(4):490-8. Minerva Endocrinol. 2016. PMID: 27600643 Review.
Cited by
-
Screening of pancreaticoduodenal endocrine tumours in patients with MEN 1: multidetector-row computed tomography vs. endoscopic ultrasound.Radiol Med. 2011 Jun;116(4):595-606. doi: 10.1007/s11547-011-0636-2. Epub 2011 Feb 1. Radiol Med. 2011. PMID: 21286942 English, Italian.
-
Non-hyperfunctioning neuroendocrine tumours of the pancreas: MR imaging appearance and correlation with their biological behaviour.Eur Radiol. 2013 Nov;23(11):3029-39. doi: 10.1007/s00330-013-2929-4. Epub 2013 Jun 21. Eur Radiol. 2013. PMID: 23793519
-
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study.Surg Endosc. 2017 Nov;31(11):4478-4484. doi: 10.1007/s00464-017-5501-5. Epub 2017 Apr 3. Surg Endosc. 2017. PMID: 28374260 Clinical Trial.
-
Isoattenuating insulinomas at biphasic contrast-enhanced CT: frequency, clinicopathologic features and perfusion characteristics.Eur Radiol. 2016 Oct;26(10):3697-705. doi: 10.1007/s00330-016-4216-7. Epub 2016 Jan 26. Eur Radiol. 2016. PMID: 26815370
-
Imaging of Pancreatic Neuroendocrine Neoplasms.Int J Environ Res Public Health. 2021 Aug 24;18(17):8895. doi: 10.3390/ijerph18178895. Int J Environ Res Public Health. 2021. PMID: 34501485 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials